CJC-1295 DAC - HILMA BIOCARE

Product Overview:
Introduced in 2005 by the Canadian biotechnology firm ConjuChem, CJC-1295 DAC offers a unique approach to growth hormone release. Unlike GHRP peptides, CJC-1295 DAC facilitates a steady, gradual release of growth hormone, mimicking its effects. Following a single injection, CJC-1295 DAC elevates hormone levels in the bloodstream by 2-10 times over six days. Widely utilized by athletes for performance enhancement purposes.

Effects:
Athletes utilizing CJC-1295 DAC can expect enhanced muscle gains and performance alongside fat reduction. Moreover, it promotes collagen synthesis, fortifying tendons and ligaments, and contributes to overall bodily well-being.

Adverse Effects:
As a peptide, CJC-1295 DAC does not induce adverse reactions typically associated with anabolic steroids. The most prevalent side effects associated with CJC-1295 DAC include mild water retention and occasional weakness.

Combination Usage:
CJC-1295 DAC yields remarkable outcomes and can be safely combined with other peptides, as well as with AAS (anabolic-androgenic steroids) and HGH (human growth hormone).

We invite you to verify the authenticity and quality of our products.